Phio Pharmaceuticals Corp. (PHIO) Presents New Data for Targeting of BRD4 with PH-894 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Phio Pharmaceuticals Corp. announced the poster presentation of two key preclinical studies of its INTASYL compound PH-894 at the AACR-NCI-EORTC International Conference on Molecular Targets and.
Phio Pharmaceuticals Corp (NASDAQ: PHIO) shares are trading higher after the company announced the poster presentation of two preclinical studies of its INTASYL compound PH-894 at the AACR-NCI-EORTC International Conference on Molecular
U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Wednesday. The Dow traded down 0.19% to 33,674.66 while the NASDAQ rose 0.18% to 13,586.67. The S&P 500 also rose, gaining, 0.12% to 4,353.19.